Discover 512 paid clinical trials in Iowa City, Iowa. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 512
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
for
Hematologic Disorder, Bleeding Disorder,
Location: Iowa City IA, Peoria IL, Rochester MN, Chicago IL,
Sponsor: American Thrombosis and Hemostasis Network
Sex: All
Age: 0+
Code: NCT04398628
Recruiting
Empagliflozin Treatment in Kidney Transplant Recipients
for
Kidney Transplant, Chronic Kidney Disease
Location: Iowa City IA, Hines IL, Omaha NE, Nashville TN,
Sponsor: VA Office of Research and Development
Sex: All
Age: 19+
Code: NCT06013865
Recruiting
CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
for
End-Stage Kidney Disease, End-Stage Renal Disease
Location: Iowa City IA, Omaha NE, Minneapolis MN, Decatur GA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05931276
Phase3, Recruiting
Tailor VHA HH Bundle for Acute Mental Health Care
for
Hand Hygiene Compliance
Location: Iowa City IA, Madison WI, Hines IL, Minneapolis MN
Sponsor: VA Office of Research and Development
Sex: All
Age: 18 - 70+
Code: NCT07607145
Recruiting
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
for
Prediabetic State, Atherosclerosis, Metformin
Location: Iowa City IA, Hines IL, Milwaukee WI, Omaha NE,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT02915198
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Biorepository and Registry for Plasma Exchange Patients
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Iowa City IA, O'Fallon MO, Edmond OK, Oklahoma City OK,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT07196501
Phase3, Recruiting
Study of ATX-01 in Participants With DM1
for
Myotonic Dystrophy 1
Location: Iowa City IA, Fairway KS, Richmond VA, Gainesville FL,
Sponsor: ARTHEx Biotech S.L.
Sex: All
Age: 18 - 64
Code: NCT06300307
Phase1, Phase2, Recruiting
Palbociclib and Pembrolizumab in Sarcoma
for
Sarcoma
Location: Iowa City IA
Sponsor: John Rieth
Sex: All
Age: 12+
Code: NCT06113809
Phase1, Recruiting
StrokeNet Thrombectomy Endovascular Platform
for
Ischemic Stroke
Location: Iowa City IA, Chicago IL, St Louis MO, Edina MN,
Sponsor: Medical University of South Carolina
Sex: All
Age: 18+
Code: NCT06289985
Recruiting
COVID-19 Coagulopathy Extension Study
for
COVID-19
Location: Iowa City IA
Sponsor: University of Iowa
Sex: All
Age: 18 - 70+
Code: NCT05334615
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for
Non Small Cell Lung Cancer, Esophageal Cancer,
Location: Iowa City IA, Chicago IL, Louisville KY, Nashville TN,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT05983432
Phase1, Recruiting
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Location: Iowa City IA, Madison WI, Saint Louis MO, Detroit MI,
Sponsor: TopAlliance Biosciences
Sex: All
Age: 18+
Code: NCT04137900
Phase1, Recruiting
Oxytocin and Fetal Heart Rate Changes
for
Fetal Bradycardia Complicating Labor and Delivery,
Location: Iowa City IA
Sponsor: Unyime Ituk
Sex: Female
Age: 18 - 55
Code: NCT03232918
Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Iowa City IA, Waukee IA, Madison WI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
for
Burns
Location: Iowa City IA, Washington D.C. DC, Phoenix AZ,
Sponsor: Skingenix, Inc.
Sex: All
Age: 18+
Code: NCT01297400
Phase2, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML